Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 78.97 USD 0.32% Market Closed
Market Cap: 18.3B USD
Have any thoughts about
Hologic Inc?
Write Note

Hologic Inc
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hologic Inc
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Hologic Inc
NASDAQ:HOLX
Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Common Stock
$17m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
1%
Stryker Corp
NYSE:SYK
Common Stock
$38m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
0%
Abbott Laboratories
NYSE:ABT
Common Stock
$24.9B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Common Stock
$400k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hologic Inc
Glance View

Market Cap
18.3B USD
Industry
Health Care

Hologic Inc. is a leading global medical technology company dedicated to improving women's health through innovative diagnostics, medical imaging, and surgical products. Founded in 1982, Hologic has carved out a niche in the healthcare sector, specifically focusing on areas such as breast health, cervical health, and skeletal health. The company’s flagship products include advanced breast imaging systems and molecular diagnostics, which enable early disease detection and improve patient outcomes. As awareness and demand for women's health services continue to grow, Hologic stands out as a key player, consistently investing in research and development to stay at the forefront of medical innovation. For investors, Hologic represents a promising opportunity with its robust portfolio and strategic positioning in expanding markets. The company has experienced significant growth, driven by its commitment to addressing critical health issues, particularly in breast cancer screening and gynecological diagnostics. With a track record of strong financial performance and a resilient business model, Hologic is poised to benefit from tailwinds in healthcare spending and increasing emphasis on preventive care. As societal shifts continue to favor healthcare advancements that prioritize women's health, Hologic's consistent revenue growth and strategic acquisitions create a compelling case for investment, establishing it as a company well equipped to thrive in an evolving marketplace.

HOLX Intrinsic Value
81.31 USD
Undervaluation 3%
Intrinsic Value
Price

See Also

Back to Top